Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases–INVITATION Trial–
Takuhiro Shirakawa(Fukuoka Tokushukai Hospital), Kenichi Tsujita(Kumamoto University), Toshiyuki Matsumura(Japan Organization of Occupational Health and Safety), Hisao Ogawa(Kumamoto University Hospital), Kenji Sakamoto(Kumamoto University), Ryusuke Tsunoda(Japanese Red Cross Kumamoto Hospital), Hideki Shimomura(Fukuoka Tokushukai Hospital), Yasuhiro Nagayoshi(Kumamoto University), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Nobuyasu Yamamoto(Miyazaki Prefectural Hospital), Naritsugu Sakaino, Shinichi Nakamura(Sumitomo Dainippon Pharma (Japan)), Eiichiro Yamamoto(Sapporo Medical University), Seiji Hokimoto(Kumamoto University), Koichi Kaikita(Kumamoto University), Kazuteru Fujimoto(Kumamoto Medical Center), Kōichi Nakao(Kanazawa Seiryo University), Koichiro Fujisue(Kumamoto University), Shuichi Oshima(Kumamoto Chuo Hospital), Toyoki Hirose, Yasuhiro Izumiya(Kumamoto University), Shunichi Koide(Kumamoto Medical Center), Nobutaka Hirai(Kumamoto Medical Center), Koichi Kikuta(Beppu Medical Center), Shinji Tayama(Saiseikai Kumamoto Hospital), Ichiro Kajiwara, Hideki Maruyama, Jun Hokamaki
Cited by 4
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k